Your browser doesn't support javascript.
loading
Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report.
Kerpel-Fronius, Anna; Tammemägi, Martin; Cavic, Milena; Henschke, Claudia; Jiang, Long; Kazerooni, Ella; Lee, Choon-Taek; Ventura, Luigi; Yang, Dawei; Lam, Stephen; Huber, Rudolf M.
Afiliación
  • Kerpel-Fronius A; Országos Korányi Pulmonológiai Intézet, National Korányi Institute for Pulmonology, Budapest, Hungary. Electronic address: kerpel.anna@gmail.com.
  • Tammemägi M; Prevention and Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada; Department of Health Sciences, Brock University, St. Catharines, Ontario, Canada.
  • Cavic M; Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Belgrade, Serbia.
  • Henschke C; Department of Radiology, Icahn School of Medicine, Mount Sinai Hospital, New York, New York.
  • Jiang L; Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Kazerooni E; Division of Cardiothoracic Radiology and Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
  • Lee CT; Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea; Department of Internal Medicine and Respiratory Center, Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Ventura L; Thoracic Surgery, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Yang D; Department of Pulmonary Medicine and Critical Care, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lam S; Department of Integrative Oncology, British Columbia Cancer Research Institute, Vancouver, British Columbia, Canada; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Huber RM; Division of Respiratory Medicine and Thoracic Oncology, Department of Internal Medicine V Thoracic Oncology Centre Munich University of Munich-Campus Innenstadt Munich, Germany, member of the German Center for Lung Research (DZL - CPC-M).
J Thorac Oncol ; 17(1): 56-66, 2022 01.
Article en En | MEDLINE | ID: mdl-34455065
ABSTRACT
Screening with low-dose computed tomography of high-risk individuals with a smoking history reduces lung cancer mortality. Current screening guidelines and eligibility criteria can miss more than 50% of lung cancers, and in some geographic areas, such as East Asia, a large proportion of the missed lung cancers are in never-smokers. Although randomized trials revealed the benefits of screening for people who smoke, these trials generally excluded never-smokers. Thus, the feasibility and effectiveness of lung cancer screening of individuals who never smoked are uncertain. Several known and suspected risk factors for lung cancers in never-smokers such as exposure to secondhand smoke, occupational carcinogens, radon, air pollution, and pulmonary diseases, such as chronic obstructive pulmonary disease and interstitial lung diseases, and intrinsic factors, such as age, are well noted. In this regard, knowledge of risk factors may make possible quantification and prediction of lung cancer risk in never smokers. It is worth considering if and how never smokers could be included in population-based screening programs. As the implementation of these programs is challenging in many countries owing to multiple factors and the epidemiologic differences by global regions, these issues will need to be evaluated in each country taking into account various factors, including accuracy of risk assessment and cost-effectiveness of screening in never smokers. This report aims to outline current knowledge on risk factors for lung cancer in never smokers to propose research strategies for this topic and initiate a broader discussion on lung cancer screening of never smokers. Similar considerations can be made in current and ex-smokers, which do not fulfill the current screening inclusion criteria, but otherwise are at increased risk. Although screening of never smokers may in the future be effectively conducted, current evidence to support widespread implementation of this practice is lacking.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Detección Precoz del Cáncer / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Detección Precoz del Cáncer / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article